Entities / Company
Abbott Laboratories.
American global health care and medical device products company
- Reports this week
- 5
- Active events
- 5
- Connections
- 294
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.Some support7 reports
-
Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Erie Indemnity.Some support3 reports
-
Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.Some support2 reports1 development inside
-
AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.Some support2 reports1 development inside
-
ExxonMobil and Abbott Laboratories are being discussed as high-dividend stocks suitable for retirees.Some support1 report
Earlier this month
-
Conavi Medical Corp. received FDA clearance for its system, which is used in the cardiovascular imaging sector.Some support1 report
-
Abbott Laboratories has facilities located in the states of Michigan and Arizona.Some support1 report
-
Abbott Laboratories is under investigation by the Justice Department regarding manufacturing and product recalls.Some support1 report
-
Product recalls and safety inquiries affect national formula supply following FDA oversight in Sturgis.Well supported19 reports
-
Market pressure due to cost trends is affecting major companies including UnitedHealth Group, Molina Healthcare, Abbott Laboratories, and Eli Lilly, as reported on Investopedia.Some support1 report6 developments inside
-
Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.Some support1 report
-
Nvidia and Abbott Laboratories are being discussed as a comparative market signal.Some support1 report
-
The Saudi Central Bank has increased its stake/position in Abbott Laboratories.Some support1 report
-
Companies including UnitedHealth Group, Procter & Gamble, Abbott Laboratories, and Merck are noted as being included in high-quality dividend ETFs.Some support1 report1 development inside
-
The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.Some support1 report
One to three months ago
-
Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.Some support1 report
-
A Missouri appeals court upheld a verdict in a settlement case involving an Illinois mother, with federal cases consolidated in Chicago.Some support2 reports
-
Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.Some support2 reports1 development inside
-
Google Health and Abbott Laboratories are collaborating on a multiyear project to integrate Lingo CGM data.Some support2 reports
-
Thrivent Financial for Lutherans increased its stock position in Abbott Laboratories on August 15, 2026.Some support1 report
-
Cencora is identified as a wholesale distributor for AbbVie, while both AbbVie and Abbott Laboratories are noted as healthcare industry leaders.Some support4 reports
-
Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.Well supported9 reports
-
Abbott Laboratories and Amgen are major holdings in the SCHD ETF.Some support1 report
-
Meta's offerings are being improved by AI, while Foundry and Abbott Laboratories are noted as major AI platforms in global health/tech.Some support2 reports
-
Benchmark reduced its price target and set a buy rating for Abbott Laboratories, while Royal Bank of Canada issued an outperform rating on July 29, 2026.Some support2 reports
-
Trump DOJ declines to charge several corporations, signaling a softer approach to corporate crime.Some support1 report
-
Abbott Laboratories increased its stake in DHG Pharmaceutical to controlling interest (51.7 percent) in Việt Nam.Some support2 reports
-
Bank of America cut price objective and Daiwa Securities Group published research reports on Abbott Laboratories stock.Some support2 reports
-
Abbott Laboratories' stock surged +10.7% on July 17, 2026, while the S&P 500 index experienced a decline.Some support1 report
-
A representative made various stock transactions on July 18, 2026, including buying shares of Abbott Laboratories, Intercontinental Exchange, and L3Harris Technologies, while also selling shares of BlackRock, Analog Devices, and UnitedHealth Group. Truist Financial raised the L3Harris rating.Some support5 reports
-
A financial transaction involving stock sales between companies including Intuit, Procter & Gamble, S&P Global, and Abbott Laboratories.Some support1 report2 developments inside
-
Rick Larsen and MCK made stock transactions involving Amphenol, S&P Global, McKesson, and Abbott Laboratories on July 18, 2026.Some support5 reports
-
Abbott Laboratories and Analog Devices are publicly traded companies operating within the relevant sector.Some support2 reports
-
The iShares U.S. Medical Devices ETF holds significant shares of a medical device company.Some support3 reports
-
Josh Gottheimer made various stock transactions on July 9, 2026, including purchasing shares of Micron Technology and selling shares of Nintendo, Abbott Laboratories, Intuit, and Alibaba Group.Some support1 report
-
Invesco ETF holds significant shares of both Abbott Laboratories and AbbVie.Some support3 reports
-
The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.Well supported6 reports
-
Abbott Laboratories faces a nationwide infant formula recall and DOJ investigation following a cronobacter outbreak.Some support1 report
-
Abbott Laboratories and Mead Johnson are major manufacturers of infant formula.Some support9 reports
Gone quiet
No new reports in 90+ days-
AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.Well supported9 reports
-
A luxury group is facing bankruptcy following a cybersecurity clampdown on a top U.S. AI, concurrent with the DOJ dropping charges against a company.Some support1 report
-
Abbott Laboratories is based in Illinois.Some support2 reports
-
Reuters reported on a federal judge's ruling involving Abbott Laboratories.Some support4 reports
-
Abbott Laboratories' market valuation and company strategy were discussed on CNBC.Some support1 report
-
Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.Some support2 reports
-
Abbott Laboratories and TerrAscend are competing for market share as medical companies.Some support6 reports
-
Citi reiterated a Buy rating on Abbott stock while BofA lowered its recommendation, amid tariffs benefiting AI stocks.Some support1 report
-
Products of Abbott Laboratories align with updated colorectal cancer screening guidelines.Some support1 report
-
A representative sold shares of Abbott Laboratories on June 1, 2026.Some support1 report
-
Rick W. Allen sold shares of Procter & Gamble, Intuit, Abbott Laboratories, and Ameriprise Financial on June 10, 2026.Some support1 report
-
AbbVie maintains operations in Dublin, while Abbott Laboratories operates manufacturing sites and employs staff across Ireland, including Cork.Some support1 report
-
TD Cowen reduced its target price and maintained a 'buy' rating for Abbott Laboratories, while the company also filed 13F reports with the SEC.Some support1 report
-
Abbott's sensor system integrates with Tandem's pump, with the Volt system being a key confidence driver.Speculative2 reports
-
Illumina, AbbVie, Abbott Laboratories, Qiagen, and Eli Lilly are major players in the US personalized medicine market and are investing in related R&D.Some support1 report1 development inside
-
Abbott Laboratories and Roche are key players in the Kenyan IVD market.Some support1 report
-
Market growth and trade activity involving major companies like Abbott, Roche, Siemens, and Danaher in Africa.Some support1 report
-
Abbott Laboratories (Q306764) uses ABT (Q4650427) as its ticker symbol, operates the Vascular segment (Q120967828), and saw organic sales improve in key emerging markets including Asia (Q123890313).Some support1 report1 development inside
-
Kadant, Bio-Techne, Nike, and Abbott Laboratories were noted on July 3, 2025, as high-quality, large-cap companies included in the S&P 500.Speculative1 report
-
Visa and Abbott Laboratories are leaders in their respective industries.Some support1 report
-
Envista Holdings Corporation and Abbott Laboratories are classified as stocks in the Medical - Products sector.Some support3 reports
No events began in the chosen period. Widen it, or reset.
What's reaching Abbott Laboratories
Recent events traced to Abbott Laboratories, step by stepAround Abbott Laboratories this week
News at the entities that move Abbott Laboratories most-
Exact Sciences StructuralZacks Investment Research provided stock analysis and ratings for Exact Sciences.Moves Abbott Laboratories
-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Abbott Laboratories
-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Abbott Laboratories
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves Abbott Laboratories
-
Securities and Exchange Commission StructuralBlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Moves Abbott Laboratories
-
Johnson & Johnson OperationalP&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Moves Abbott Laboratories
Connections
The 40 strongest of 294, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sturgis Structural
A critical factory facility of Abbott Laboratories was located in Sturgis, producing a fifth of the national baby formula supply before a major contamination incident forced facility closure and product recall.
-
Exact Sciences Structural
Abbott Laboratories acquired Exact Sciences, which is now fully integrated as a subsidiary.
-
Senseonics (United States) Transactional
Abbott Laboratories acquired shares in Senseonics through a private placement deal.
-
Johnson & Johnson Operational
Both companies are major healthcare giants that actively compete for market share through product innovation and strategic moves.
-
FDA Structural
The FDA establishes the regulatory framework, granting market access and setting operational standards for Abbott Laboratories products.
-
SEC Structural
Abbott operates under the mandatory filing and oversight requirements of the U.S. Securities and Exchange Commission (SEC).
-
Boston Scientific Operational
Abbott Laboratories and Boston Scientific are direct competitors in the medical devices industry, vying for market share through innovation and strategic moves.
-
Food and Drug Administration Structural
The FDA exercises formal regulatory authority over Abbott Laboratories concerning product safety and facility operations.
Show all 40 connections
-
Robert Ford Structural
Robert Ford holds the position of CEO at Abbott Laboratories.
-
Donald Trump Operational
Donald Trump's political policies and regulatory actions directly influence Abbott Laboratories' business environment and legal standing.
-
Europe Transactional
Abbott receives formula imports from Europe, often via airlift, to meet demand during shortages.
-
Mead Johnson Operational
Both companies are major competitors in the infant formula manufacturing industry.
-
Dexcom Operational
Dexcom and Abbott Laboratories are fierce competitors operating within the glucose monitoring market.
-
ABR Operational
ABR provides brokerage recommendations calculated based on Abbott's stock performance and actively suggests buying the stock.
-
Volt Structural
Volt's systems are identified as a key confidence driver for Abbott Laboratories' operations.
-
representative Transactional
Representative bought and sold shares of Abbott Laboratories.
-
Robert Ford Mentioned together
Robert Ford serves as the CEO of Abbott Laboratories, influencing its market outlook and operational direction.
-
Tandem Structural
Abbott Laboratories plans to integrate its offerings with Tandem's insulin pumps.
-
Missouri Structural
Abbott Laboratories is subject to the legal jurisdiction and appeals court system of Missouri.
-
Vijay Kumar Operational
Vijay Kumar, acting as a market analyst, issued a rating downgrade on Abbots Laboratories' stock.
-
Synlait Transactional
Abbott discussed acquiring Synlait's Pokeno facility, which was subsequently sold as part of a larger asset divestiture.
-
Manufacturers Life Insurance Company Structural
Manufacturers Life Insurance Company purchased a new stake in Abbott Laboratories stock, establishing an ownership relationship.
-
Google Health Operational
Google Health and Abbott Laboratories are engaged in a multiyear collaboration to integrate CGM data.
-
AbbVie Transactional
The companies were formerly linked as a division/subsidiary before a major spin-off occurred in 2013, and they now operate as competitors.
-
Stericycle Operational
The two companies are observed to be operating in a shared high-risk environment due to involvement in corporate crime issues.
-
Securities and Exchange Commission Structural
Abbott Laboratories operates under the regulatory oversight of the Securities and Exchange Commission, evidenced by required 13F filings.
-
SPX Shared context
Abbott operates within the market context represented by the SPX index.
-
Eli Lilly and Company Operational
Abbott Laboratories and Eli Lilly and Company are major industry players engaged in active competition within the global pharmaceutical and healthcare products markets.
-
Illinois Shared context
Abbott Laboratories operates and is subject to legal matters within the jurisdiction of Illinois.
-
Bank of America Operational
Bank of America has issued price target adjustments for Abbott Laboratories' stock.
-
Rick Larsen Transactional
Rick Larsen sold shares of Abbott Laboratories on July 18, 2026.
-
Thermo Fisher Scientific Inc. Operational
The companies are major healthcare providers and compete in the market.
-
Medtronic plc Operational
Both Abbott and Medtronic are identified as key competitors and players within the healthcare device and tissue engineering markets.
-
Dublin Shared context
Abbott operates manufacturing sites and employs workers in Ireland, placing the company within the economic sphere of influence of Dublin.
-
Intuitive Surgical Operational
Both companies operate as peers in the competitive healthcare equipment and supplies market.
-
Intuit Mentioned together
Both Intuit and Abbott Laboratories are publicly traded companies.
-
Baird Mentioned together
Baird initiated investment coverage on Abbott Laboratories with an Outperform rating.
-
Coca-Cola Mentioned together
Both Coca-Cola and Abbott Laboratories are co-mentioned as top holdings in the SCHD ETF.
-
Pfizer Mentioned together
Both companies are noted for offering different dividend stories to investors.
-
Barclays Mentioned together
Barclays analysts provide price targets and market commentary for Abbott Laboratories.
History
Events by the month they beganSeptember 2026
8 events- ExxonMobil and Abbott Laboratories are being discussed as high-dividend stocks suitable for retirees.
- Conavi Medical Corp. received FDA clearance for its system, which is used in the cardiovascular imaging sector.
- Abbott Laboratories has facilities located in the states of Michigan and Arizona.
- Abbott Laboratories is under investigation by the Justice Department regarding manufacturing and product recalls.
- Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.
- Nvidia and Abbott Laboratories are being discussed as a comparative market signal.
- The Saudi Central Bank has increased its stake/position in Abbott Laboratories.
- The Schwab U.S. Dividend Equity ETF now includes Procter & Gamble, Abbott Laboratories, and Merck among its top 10 holdings.
August 2026
6 events- Medtronic plc, Intuitive Surgical, Inc., and Abbott Laboratories are leaders in medical device technology and are currently facing market valuation pressures.
- A Missouri appeals court upheld a verdict in a settlement case involving an Illinois mother, with federal cases consolidated in Chicago.
- Google Health and Abbott Laboratories are collaborating on a multiyear project to integrate Lingo CGM data.
- Thrivent Financial for Lutherans increased its stock position in Abbott Laboratories on August 15, 2026.
- Cencora is identified as a wholesale distributor for AbbVie, while both AbbVie and Abbott Laboratories are noted as healthcare industry leaders.
- Abbott Laboratories and Amgen are major holdings in the SCHD ETF.
July 2026
15 events- Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.
- Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.
- Benchmark reduced its price target and set a buy rating for Abbott Laboratories, while Royal Bank of Canada issued an outperform rating on July 29, 2026.
- Trump DOJ declines to charge several corporations, signaling a softer approach to corporate crime.
- Abbott Laboratories increased its stake in DHG Pharmaceutical to controlling interest (51.7 percent) in Việt Nam.
- Bank of America cut price objective and Daiwa Securities Group published research reports on Abbott Laboratories stock.
- Abbott Laboratories' stock surged +10.7% on July 17, 2026, while the S&P 500 index experienced a decline.
- A representative made various stock transactions on July 18, 2026, including buying shares of Abbott Laboratories, Intercontinental Exchange, and L3Harris Technologies, while also selling shares of BlackRock, Analog Devices, and UnitedHealth Group. Truist Financial raised the L3Harris rating.
- Rick Larsen and MCK made stock transactions involving Amphenol, S&P Global, McKesson, and Abbott Laboratories on July 18, 2026.
- Abbott Laboratories and Analog Devices are publicly traded companies operating within the relevant sector.
- Josh Gottheimer made various stock transactions on July 9, 2026, including purchasing shares of Micron Technology and selling shares of Nintendo, Abbott Laboratories, Intuit, and Alibaba Group.
- Invesco ETF holds significant shares of both Abbott Laboratories and AbbVie.
- The Schwab U.S. Dividend Equity ETF holds Abbott Laboratories, Merck, and Coca-Cola as among its top holdings.
- Abbott Laboratories faces a nationwide infant formula recall and DOJ investigation following a cronobacter outbreak.
- Abbott Laboratories and Mead Johnson are major manufacturers of infant formula.
Show 1 earlier month
June 2026
31 events- MarketBeat listed Abbott, Eli Lilly, Pfizer, Gilead, AbbVie, and McKesson as stocks to watch on June 7, 2026.
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Erie Indemnity.
- AbbVie, Abbott Laboratories, and Johnson & Johnson were recommended as dividend stocks for retirees, operating in the healthcare sector.
- Product recalls and safety inquiries affect national formula supply following FDA oversight in Sturgis.
- Market pressure due to cost trends is affecting major companies including UnitedHealth Group, Molina Healthcare, Abbott Laboratories, and Eli Lilly, as reported on Investopedia.
- Companies including UnitedHealth Group, Procter & Gamble, Abbott Laboratories, and Merck are noted as being included in high-quality dividend ETFs.
- Abbott Laboratories is discussing the acquisition of Synlait's Pokeno facility and considering other facilities in New Zealand.
- Meta's offerings are being improved by AI, while Foundry and Abbott Laboratories are noted as major AI platforms in global health/tech.
- A financial transaction involving stock sales between companies including Intuit, Procter & Gamble, S&P Global, and Abbott Laboratories.
- The iShares U.S. Medical Devices ETF holds significant shares of a medical device company.
- AbbVie and Abbott Laboratories are large healthcare companies whose corporate histories are linked by a major split that occurred in 2013.
- A luxury group is facing bankruptcy following a cybersecurity clampdown on a top U.S. AI, concurrent with the DOJ dropping charges against a company.
- Abbott Laboratories is based in Illinois.
- Reuters reported on a federal judge's ruling involving Abbott Laboratories.
- Abbott Laboratories' market valuation and company strategy were discussed on CNBC.
- Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.
- Abbott Laboratories and TerrAscend are competing for market share as medical companies.
- Citi reiterated a Buy rating on Abbott stock while BofA lowered its recommendation, amid tariffs benefiting AI stocks.
- Products of Abbott Laboratories align with updated colorectal cancer screening guidelines.
- A representative sold shares of Abbott Laboratories on June 1, 2026.
- Rick W. Allen sold shares of Procter & Gamble, Intuit, Abbott Laboratories, and Ameriprise Financial on June 10, 2026.
- AbbVie maintains operations in Dublin, while Abbott Laboratories operates manufacturing sites and employs staff across Ireland, including Cork.
- TD Cowen reduced its target price and maintained a 'buy' rating for Abbott Laboratories, while the company also filed 13F reports with the SEC.
- Abbott's sensor system integrates with Tandem's pump, with the Volt system being a key confidence driver.
- Illumina, AbbVie, Abbott Laboratories, Qiagen, and Eli Lilly are major players in the US personalized medicine market and are investing in related R&D.
- Abbott Laboratories and Roche are key players in the Kenyan IVD market.
- Market growth and trade activity involving major companies like Abbott, Roche, Siemens, and Danaher in Africa.
- Abbott Laboratories (Q306764) uses ABT (Q4650427) as its ticker symbol, operates the Vascular segment (Q120967828), and saw organic sales improve in key emerging markets including Asia (Q123890313).
- Kadant, Bio-Techne, Nike, and Abbott Laboratories were noted on July 3, 2025, as high-quality, large-cap companies included in the S&P 500.
- Visa and Abbott Laboratories are leaders in their respective industries.
- Envista Holdings Corporation and Abbott Laboratories are classified as stocks in the Medical - Products sector.